Drawing for EVABAVE

USPTO serial 90730812

EVABAVE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
SALES, HEATHER ALISON
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EVABAVE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bruce W. Longbottom

LILLY CORPORATE CENTERINDIANAPOLIS, IN 46285United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseasesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 14, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 14, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 2, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 2, 2024EX5GSOU EXTENSION 5 GRANTED
Oct 2, 2024EXT5SOU EXTENSION 5 FILED
Oct 2, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 15, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 14, 2024EX4GSOU EXTENSION 4 GRANTED
Mar 14, 2024EXT4SOU EXTENSION 4 FILED
Mar 14, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 19, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 17, 2023EX3GSOU EXTENSION 3 GRANTED
Apr 17, 2023EXT3SOU EXTENSION 3 FILED
Apr 17, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 17, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 15, 2023EX2GSOU EXTENSION 2 GRANTED
Mar 15, 2023EXT2SOU EXTENSION 2 FILED
Mar 15, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 1, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 30, 2022EX1GSOU EXTENSION 1 GRANTED
Sep 30, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 19, 2022EXT1SOU EXTENSION 1 FILED
Sep 19, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 5, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 8, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 8, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 19, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 6, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 5, 2022DOCKASSIGNED TO EXAMINER
Aug 19, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 27, 2021NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance